PIK3CA and neoplasm: PIK3CA-mutations were significantly more frequent in well and intermediately compared to poorly differentiated tumours (G1, OR 3.13, 95% CI 1.970–4.986; G2, OR 2.14, 95% CI 1.478–3.085).